Conditions: Parkinson's Disease
Keywords: Rotigotine NEUPRO® Parkinson's Disease (PD) perioperative use anaesthesia,
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 14
Healthy volunteers: no

Brief summary:
Evaluation of efficacy and safety on the use of rotigotine in patients suffering from Parkinson's Disease during and after surgery requiring general anaesthesia.

Detailed description:

Arms:
arm 1: Rotigotine

Interventions: intervention 1: Rotigotine
Intervention descriptions: intervention 1: 2 mg/24 h, 4 mg/24 h, 6 mg/24 h and 8 mg/24 h patch;

Single patches and a combination of 2 of these patches for a dosage of up to 16 mg/24 h;

One (1) regimen on day of surgery, but exceptionally extended for up to 2 (two) weeks if the patient requires unexpected ventilation after surgery.

Protocol document: